Company:1 Northern State Medical University of Ministry of Health of the Russian Federation, Troitskiy prospekt, 51, Arkhangelsk, 163001, Russian Federation 2 E.E. Volosevich First City Clinical Hospital of the Arkhangelsk region,
ulitsa Suvorova, 1, Arkhangelsk, 163001, Russian Federation
For citation:
Mirolyubova O.A., Moseeva A.S., Shonbin A.N. The role of obesity in the dynamics of renal function and Fas-mediated apoptosis after off-pump coronary artery bypass on a beating heart. Creative Cardiology. 2018; 12 (2): 146–58 (in Russ.). DOI: 10.24022/1997-3187-2018-12-2-146-158
Received / Accepted:August 23, 2017 / September 22, 2017
Objective. To assess the effect of obesity on activation of Fas-mediated apoptosis and glomerular kidney function in heart failure with preserved ejection fraction (HF-pEF) patients after off-pump coronary artery bypass (OPCAB).
Material and methods. 30 patients with HF-pEF survived OPCAB were included. Two groups were formed: with obesity and without obesity, which did not differ by sex and age. Soluble Fas receptor (sFas), sFas ligand (sFasL), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) were assessed by ELISA before the operation, in 48 h and 7 days after OPCAB. The changes of glomerular filtration rate (GFR) were determined in 7 days and 1 year after OPCAB.
Results. We revealed significant increase of sFasL in obese patients and lower values of antiapoptotic sFas in com- mon group in 48 h after OPCAB. There was different dynamics of GFR: increase in patients without obesity and reduction in obese in 1 year after OPCAB. GFR in patients without obesity was higher than in obese patients over year (111.0±22.2 vs 82.0±25.0 ml/min/1.73 m2; p=0.005). Such a difference was absent before surgery. Body mass index over 28 kg/m2 appeared to be GFR reduction predictor in 1 year after OPCAB.
Conclusion. In the early period after OPCAB apoptosis process activation with higher sFasL in 48 hours in obese patients and lower of antiapoptotic factor sFas levels were identified. Changes of GFR were associated with obesity: we revealed GFR reduction in obese patients and increased in those without obesity after OPCAB meaning the follow-up necessity in obese patients.
Acknowledgements. The study had no sponsorship Conflict of interest. The authors declare no conflict of interest.
References
Ter Maaten J.M., Damman K., Verhaar K.M., Paulus W.J., Duncker D.J., Cheng C. et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur. J. Heart Fail. 2016; 18: 588–98. DOI: 10.1002/ejhf.497
Brunner H., Cockcroft J.R., Deanfield J., Do- nald A., Ferrannini E., Halcox J. et al. Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endo- thelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J. Hypertens. 2005; 23: 233–46
Campbell D.J., Somaratne J.B., Prior D.L., Yii M., Kenny J.F., Newcomb A.E., Kelly D.J., Black M.J. Obesity is associated with lower coronary microvascular density. PLoS One. 2013; 8 (11): e81798. DOI: 10.1371/journal.pone.0081798
Hoenig M.R., Bianchi C., Rosenzweig A., Sellke F.W. The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr. Vasc. Pharmacol. 2008; 6: 292–300. DOI: 10.2174/157016108785909779
Gottlieb R.A., Burleson K.O., Kloner R.A. et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 1994; 94 (4): 1621–8. DOI: 10.1172/JCI117504
Ost’adal B., Kolar F. Cardiac ischemia: from injury to protection. Boston; 1999
Engler R.L., Gottlieb R.A., Burleson K.O., Babior B.M. Myocyte cell death by apoptosis during reperfusion. Circulation. 1993; 88 (S1): 1–5
Savunen T., Kentala E., Perttila J. et al. Apoptosis and heat-shock proteins as indicator of a myocardial ischemiareperfusion injury. An experimental study with pigs. The 46th Annual Meeting of the Scandinavian Association for Thoracic Surgery. Abstract 119. Troudheim, Norway; 1999
Nishigaki K., Minatoguchi S., Seishima M. et al. Plasma Fas-ligand, an inducer of apoptosis, and plasma Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 1997; 29: 1214–20
James T.N. Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am. J. Cardiol. 1990; 65: 12G–22G
Shah S.J., Katz D.H., Selvaraj S., Burke M.A., Yancy C.W., Gheorghiade M. et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015; 131: 269–79. DOI: 10.1161/CIRCULATIONAHA.114.010637
Ponikowski P., Voors A., Anker S., Bueno H., Cleland J., Coats A. et al. Рекомендации ESC ПО диагностике и лечению острой и хронической сердечной недостаточности 2016. Российский кардиологический журнал. 2017; 1: 7–81. DOI: 10.15829/1560-4071-2017-1-7-81
Mirolyubova O.A., Alekseeva M.A., Yakovleva A.S., Shonbin A.N. Acute kidney injury after coronary artery bypass grafting on the beating heart: predicting outcomes. Nephrol. Dial. 2014; 16 (3): 350–8 (in Russ.)
Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care. 2004; 8: R204–12. DOI: 10.1186/CC2872
Komarova O.V., Kucherenko A.G., Smirnov I.E., Tsygin A.N. Role of apoptosis in the progression of chronic kidney disease progression in childhood. Nephr. Dial. 2013; 15 (2): 135–9 (in Russ.)
Blanco-Colio L.M., Martin-Ventura J.L., Sol J.M. et al. Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis. J. Am. Coll. Card. 2011; 43: 1188–94. DOI: 10.1016/j.jacc.2003.10.046
Kayukov I.G., Smirnov A.V., Emanuel’ V.L. Cystatin C in carrent medicine. Nephrology. 2012; 16 (1): 22–39 (in Russ.)
Mrikaev D.V. Left ventricular diastolic dysfunction in patients with heart failure. Creative Cardiology. 2017; 11 (2): 145–58. DOI: 10.24022/1997-3187- 2017-11-2-145-158 (in Russ.)
Berezikova E.N., Pustovetova M.G., Shilov S.N., Efremov A.V., Safronov I.D., Samsonova E.N. et al. Effect of apoptosis during chronic heart failure. Circ. Pathol. Cardiosurg. 2012; 4: 55–8 (in Russ.)
Musiał K., Zwolińska D. Matrix metalloproteinas- es and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis. Apoptosis. 2011; 16: 653–9. DOI: 10.1007/s10495-011-0604-2
Shroyer A.L., Hattler B., Wagner T.H., Collins J.F., Baltz J.H., Jacquelyn R.N. et al. Five-year out- comes after on-pump and off-pump coronaryartery bypass. N. Engl. J. Med. 2017; 377: 623–32. DOI: 10.1056/NEJMoa1614341
Shumkov K.V. Outcomes and results of on- and off- pump coronary artery bypass grafting / Advantages and disadvantages of methods according to ran- domized trail data. Creative Cardiology. 2018; 12 (1): 22–30. DOI: 10.24022/1997-3187-2018-12-1-22-30 (in Russ.)
Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery
Leo Antonovich BOCKERIA,
Academician of RAS and RAMS,
President of Bakoulev National Medical Research Center for Cardiovascular Surgery
Chief Editor of the Center’s Publishing House
Cardiac surgeon; scientist and researcher; pedagogue and science organizer; doctor of medicine (1973); professor (1982); academician of RAMS (1994), academician of RAS (2011); Honored Scientist of the Russian Federation (1994); Lenin Prize (1976), State Prize of the USSR (1986), State Prize of the RF (2002) and the Government of the RF Prize (2003) laureate.
In 1994 Lео A. Bockeria was elected the Director of A.N. Bakoulev Scientific Center for Cardiovascular Surgery (SCCVS). In 1998 he became at the same time the Director of the Center for Surgical and Interventional Arrhythmology under the Ministry of Healthcare of the Russian Federation (MHС RF).
Since 1994 he has been the Head of the Department of Cardiovascular Surgery at the Russian Medical Academy of Postgraduate Education (MHC RF). Since 1995 he has been the Head of the Department of Cardiovascular Surgery № 2 (which was founded by him personally) at Moscow Medical Academy (now the First Moscow Medical University) named after I.M. Sechenov (MHC RF).
Since 2003 he has led the Department of Cardiovascular Surgery and Interventional Cardiology at Moscow State Medical and Stomatological University named after A.I. Evdokimov (MHC RF).
By his initiative the Training and Research Center ‘Modern Medical Technologies’ successfully functions, running annually 4–6 courses of postgraduate qualification improvement for senior specialists.
Lео A. Bockeria perfoms the entire known plurality of heart operations in the most various pathologies: 3–6 operations daily, that is 700–900 operations with extracorporeal circulation a year.
Since 1996 he has been the Chief Cardiac Surgeon of the MHС RF.
He is the author and co-author of more than 3700 scientific publications including more than 250 books, more than 100 inventions and utility models, more than 300 computer programs and databases, some of which are registered abroad, designed for various problems of cardiоvascular surgery, cardiology, medical education and medical science organizing.
Lео A. Bockeria is the author of the unique works dedicated to the theoretical foundation and clinical use of the method of hyperbaric oxygen therapy in heart and vessels surgery. He is the leading expert in diagnostics and surgical treatment of the heart rhythm and conduction disorders (especially tachyarrhythmias) including various combinations of heart arrhythmias with congenital and acquired defects as well as malformations, coronary disease.
He also initiated the development of another new section of cardiac surgery in Russia – minimally invasive heart surgery. He made a great contribution to the solution of the problem of coronary heart disease surgical treatment.
His role in the development of new approaches to the surgical treatment of terminal heart failure is great. The development of operations in a heavy category of cardiac patients with different forms of cardiomyopathies is his achievement. He was the first to amplify the concept of dynamic cardiomyoplasty, including that in children. Lео A. Bockeria performed the first implantation of artificial ventricle in Russia and after a long break initiated the resumption of heart transplantations in the Center.
It is by his initiative that the advanced technologies of diagnostics and reconstructive surgery of the ascending aorta and aortic arch disorders have been introduced into clinical practice.
Besides, Lео A. Bockeria ensured the development of another trend in modern medical science – creative cardiology, which determinates the necessity of the constructive cooperation of physicians representing different specialities: cardiologists, cardial surgeons, functional diagnosticians, experts in fundamental and applied disciplines.
Under the leadership of Lео A. Bockeria the new highly technological principles of prevention and treatment of patients with cardiovascular pathologies are worked out and introduced into clinical practice in the Center – namely using the methods of gene and cell therapy.
Academician Lео A. Bockeria conducts priority researches to create bioprosthetic heart valves for valve defects correction. A study of the effectiveness of myocardial protection in infants under the age of one year using new intracellular cardioplegic solution ‘Bockeria – Boldyreva’, created in the SCCVS under Bockeria’s guidance, is continued.
Lео A. Bockeria is actively engaged in methodology of medical science and pedagogical activities. He created the largest in Russia cardiac school and trained more than one generation of physicians – heart surgeons, cardiologists, resuscitators and specialists of other related professions.
Lео A. Bockeria is a scientific supervisor of 350 candidate dissertations and an advisor of more than 100 doctoral thesises. He is the creator of A.N. Bakoulev SCCVS Publishing House with its own printing office, the founder and the Chief Editor of such journals as ‘Annals of Surgery’, .‘The Bulletin of A.N. Bakoulev SCCVS Cardiovascular Diseases’, ‘Clinical Physiology of Blood Circulation’, ‘Annals of Arrhythmology’, ‘Creative Cardiology’, information collection ‘Cardiovascular Surgery’; the Chief Editor of ‘Children’s Heart and Vascular Diseases’ journal.
For his vigorous activities and contribution to the Russian healthcare system Lео A. Bockeria was aworded titles and prizes of the highest level. He is a laureat of Lenin Prize (1976), two State Prizes (1986 – USSR, 2002 – RF), the Russian Federation Government Prize (2003). For prominent achievements he was aworded The Order ‘For Merit to the Fatherland’, Grade III (1999), II (2004) and IV (2010); Georgian Order of Honor and Merit (1999); The Order of Sergius of Radonezh, Grade II (2001). The Russian Biographical Institute repeatedly gave L.A. Bockeria the honorary title ‘Person of the Year’, and in 2000 – ‘Person of the Decade’ in the category of medicine. In 2002 he got the title of the ‘Man of Legend’; the nationwide prize ‘Russian National Olympus’, established by the Government, the Union of Industrialists and the ‘Third Millennium’ fund. In 2003 as one of the world's leading cardiac surgeons Lео A. Bockeria got the international ‘Golden Hippocrates’ aword. In 2004 he was aworded the RAS Premium ‘Triumph’ in the nomination ‘Medicine – the Science of Life’ and the order ‘Maecenas’ of the charity fund ‘Maecenases of the Century’ for the outstanding сontribution to the revival and prosperity of the world, the greatness of the soul, the selfless generosity; in 2004 and 2005 – golden honorary badge ‘Public Recognition’ of the homonymous National Fund, National Civil Committee for Cooperation with the Law Enforcement, Legislative and Judicial Bodies, independent organization ‘Сivil Society’ for the great personal contribution to the developement of national medicine, for performing of the unique cardiosurgical operations using the latest medical technologies, which saved hundreds of children’s and infants’ lives, for long and fruitful scientific-practical, pedagogical and educational activities, for the active citizenship.
In 2006 Lео A. Bockeria was awarded Order of Honor ‘Public Recognition’; diploma of the Presidium of the Parliament of the Peoples of Russia ‘for the salvation of many lives, outstanding knowledge, leadership qualities, for unique personal qualities – nobleness, courage, sense of duty, the ability to cherish the honor and dignity, to keep the word and do the business, as well as for the faith in great future of the Fatherland’; Golden Medal for outstanding сontribution to the education in Russia; Golden Star ‘Honor, Pride and Glory of Russia’.
In 2008 Lео A. Bockeria got the medal ‘for practical contribution to strengthening of the nation's health’; Order of Honor with the awarding of the title ‘Support of Honest Business’ and the honorary title ‘A Distinguished Surgeon of Modern Times’. In 2009 his great contribution to the science and Russian healthcare was marked by awarding him the A.N. Kosygin Prize ‘For Great Achievements in the Development of Russian Economy’ and Moscow city Award in medicine for the development and introduction into clinical practice of the new biological heart valve ‘Bioglis’.
Lео A. Bockeria is a member of the American Association for Thoracic Surgery (1991), Board member (1992) and member of the Presidium (since 2003, consul) of the European Association for Cardio-Thoracic Surgery, Board member of the European Association for Cardiovascular Surgery, Scientific Board member of Monaco Cardio-Thoracic Center (1992), the member of the Serbian Academy of Sciences and Arts (1997), Honorary Member of the American College of Surgeons (1998), the Academician of the Ukraine AMS, Honorary Professor of M.V. Lomonosov Moscow State University (2011), the foreign member of Georgian National Academy of Sciences (2012).
He is the President of Russian Association of Cardiovascular Surgeons (1995), the President of Russian Public Organization ‘The League of Nation's Health’ (2003), the member of all convocations of the RF Public Chamber.